Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings

Shares (Q2 2026)
356,525
Value
$3.72M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RNAC by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026356,525$3.72M<0.1%+92,831+35.2%AddedHolders
Q1 2026263,694$1.62M<0.1%+8,155+3.2%AddedHolders
Q4 2025255,539$1.84M<0.1%+13,710+5.7%AddedHolders
Q3 2025241,829$2.47M<0.1%+22,902+10.5%AddedHolders
Q2 2025218,927$2.28M<0.1%−6,573−2.9%ReducedHolders
Q1 2025225,500$2.97M<0.1%+4,243+1.9%AddedHolders
Q4 2024221,257$3.96M<0.1%+85,557+63.0%AddedHolders
Q3 2024135,700$2.19M<0.1%+2,737+2.1%AddedHolders
Q2 2024132,963$3.59M<0.1%−2,365,986−94.7%ReducedHolders
Q1 20242,498,949$1.65M<0.1%+60,789+2.5%AddedHolders
Q4 20232,438,160$1.68M<0.1%+53,386+2.2%AddedHolders
Q3 20232,384,774$2.53M<0.1%+17,496+0.7%AddedHolders
Q2 20232,367,278$2.65M<0.1%+1,153,450+95.0%AddedHolders
Q1 20231,213,828$1.69M<0.1%+39,055+3.3%AddedHolders
Q4 20221,174,773$1.33M<0.1%−37,634−3.1%ReducedHolders
Q3 20221,212,407$1.99M<0.1%+72,228+6.3%AddedHolders
Q2 20221,140,179$1.49M<0.1%−595,380−34.3%ReducedHolders
Q1 20221,735,559$2.13M<0.1%−16,320−0.9%ReducedHolders
Q4 20211,751,879$5.71M<0.1%+20,598+1.2%AddedHolders
Q3 20211,731,281$7.20M<0.1%+109,033+6.7%AddedHolders
Q2 20211,622,248$6.78M<0.1%+223,505+16.0%AddedHolders
Q1 20211,398,743$6.33M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.